Key facts
- It has raised $129.2M; the latest was Later Stage VC ($50.0M) in Jul 2024.
- Notable investors include Bayern Kapital, GO Capital, Crédit Mutuel Equity, Andera Partners, Wellington Partners — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for TRiCares
- ·The full record, as it builds
Funding rounds
No funding rounds for TRiCares are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TRiCares
Developer of catheter-based valve replacement system designed for minimally invasive treatment of tricuspid valve regurgitation. The company's medical devices address tricuspid insufficiency through their anatomical conformation and their simplicity of use, enabling patients to avail of effective and lasting cures to the problem of tricuspid insufficiency.
- Sector
- Healthcare
- HQ
- Aschheim, Germany
- Founded
- 2013
- Employees
- 46
- Website
- tricares.com/
- Ownership
- Privately Held (backing)
TRiCares doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TRiCares shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TRiCares in its N-PORT filings yet. We sweep new filings monthly.